Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 5, 2026.

via HealthDay

TUESDAY, May 5, 2026 — Chronic migraine can be difficult to treat — but new research is helping identify the most effective options.

In a large new review, published today in the Annals of Internal Medicine, researchers analyzed 43 clinical trials involving adults with chronic migraine, defined as headaches on 15 or more days a month.

The strongest evidence pointed to a newer class of medications called CGRP-targeted therapies, according to the results. These drugs were shown to reduce monthly migraine days by about two and were generally well tolerated. Examples of CGRP-targeted therapies include eptinezumab (brand name, Vyepti) and atogepant (Qulipta).

CGRP is a protein found in the brain and nervous system that spikes during migraines, triggering pain and inflammation. The drugs are designed to block that process.

Available as shots, infusions, pills and a nasal spray, the drugs were also found to have fewer side effects than older treatments.

By comparison, the evidence showed botulinum toxin, or Botox, may offer some benefit but with less certainty and more side effects, leading to treatment drop-off.

For older medications like topiramate, valproate and propranolol, the evidence was also limited and even less reliable.

The researchers say more independent studies on CGRP therapies are needed, especially on long-term safety and adherence.

They add that while newer therapies appear to show the most promise, the right treatment depends on a patient's individual needs and preferences, as well as cost. They recommend talking with your health care provider to find the best option.

Malahat Khalili of the Michael G. DeGroote Institute for Pain Research and Care at McMaster University in Hamilton, Ontario, Canada, led the study.

Sources

  • HealthDay TV, May 5, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-06 02:14

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords